Use of gas sensors and FOBT for the early detection of colorectal cancer

Among the major challenges of medicine today there is the early detection of tumors, in order to prevent their degeneration into malignant stages and/or metastases. In particular, the colorectal cancer shows a high curability rate, up to 90%, if identified when in stage I. This is the reason why a r...

Full description

Saved in:
Bibliographic Details
Published in:Sensors and actuators. B, Chemical Chemical, 2018-06, Vol.262, p.884-891
Main Authors: Zonta, G., Anania, G., Feo, C., Gaiardo, A., Gherardi, S., Giberti, A., Guidi, V., Landini, N., Palmonari, C., Ricci, L., de Togni, A., Malagù, C.
Format: Article
Language:English
Subjects:
Biomarkers
Biosensors
Cancer
Clinical validation
Colorectal cancer
Degeneration
Exhalation
FOBT
Gas sensors
Medical diagnosis
Nanostructures
Principal components analysis
Risk
Screening
Sensor arrays
Statistical analysis
Statistical methods
Studies
Support vector machines
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Among the major challenges of medicine today there is the early detection of tumors, in order to prevent their degeneration into malignant stages and/or metastases. In particular, the colorectal cancer shows a high curability rate, up to 90%, if identified when in stage I. This is the reason why a reliable screening protocol is strictly necessary to avoid colorectal cancer progression. The Protocol discussed here is proposed to implement the clinical validation of a device, consisting of an array of chemoresistive semiconductor gas sensors, capable of identifying the difference between fecal exhalation of healthy subjects and of subjects suffering from high-risk colorectal adenomas or cancers. The analysis done are compared to the results of fecal occult blood test and colonoscopy as a gold standard. The difference among the two classes of fecal samples is due to the presence of tumor gaseous biomarkers, produced by cancerous cells through membrane peroxidation process and metabolic alterations. Our method combines a specific algorithm appositely created for data acquisition with principal component analysis and support vector machine. The test resulted capable of recognizing all the colorectal cancer plus high risk adenomas and the 98% of healthy subjects. The recognition capability of low-risk adenomas is progressively increasing (45%) along with statistics.
ISSN:0925-4005
1873-3077
DOI:10.1016/j.snb.2018.01.225